The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co ... with obstructive sleep apnea," said Dr. Sally Seymour of the FDA's Center for Drug ...
21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate ... "Today's approval marks the first drug ...
The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive ... with obstructive sleep apnea," said Dr. Sally Seymour, director of the Division of ...
The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea ... "This is a major step forward for patients with obstructive sleep apnea," said ...